144 related articles for article (PubMed ID: 36469984)
21. Generation of a human iPSC line (CIBi014-A) from a patient with Parkinson's disease carrying a novel heterozygotic PARK8 (LRRK2) mutation.
Li L; Si X; Yang J; Lei M; Liu H; Ruan J; Fu H; Li W; Yang H; Lei X; Sang H
Stem Cell Res; 2023 Feb; 66():102995. PubMed ID: 36528012
[TBL] [Abstract][Full Text] [Related]
22. Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease.
Biosa A; Sandrelli F; Beltramini M; Greggio E; Bubacco L; Bisaglia M
Neurobiol Dis; 2017 Dec; 108():65-72. PubMed ID: 28823929
[TBL] [Abstract][Full Text] [Related]
23. DJ-1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7.
Di Nottia M; Masciullo M; Verrigni D; Petrillo S; Modoni A; Rizzo V; Di Giuda D; Rizza T; Niceta M; Torraco A; Bianchi M; Santoro M; Bentivoglio AR; Bertini E; Piemonte F; Carrozzo R; Silvestri G
Clin Genet; 2017 Jul; 92(1):18-25. PubMed ID: 27460976
[TBL] [Abstract][Full Text] [Related]
24. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.
Kilarski LL; Pearson JP; Newsway V; Majounie E; Knipe MD; Misbahuddin A; Chinnery PF; Burn DJ; Clarke CE; Marion MH; Lewthwaite AJ; Nicholl DJ; Wood NW; Morrison KE; Williams-Gray CH; Evans JR; Sawcer SJ; Barker RA; Wickremaratchi MM; Ben-Shlomo Y; Williams NM; Morris HR
Mov Disord; 2012 Oct; 27(12):1522-9. PubMed ID: 22956510
[TBL] [Abstract][Full Text] [Related]
25. Separation of native and C106-oxidized DJ-1 proteins by using column chromatography.
Choi J; Yoo HJ; Cho K; Kim HN; Lee JH; Ryu KS
Protein Expr Purif; 2022 Aug; 195-196():106092. PubMed ID: 35430350
[TBL] [Abstract][Full Text] [Related]
26. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
27. PARK7/DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target.
Lind-Holm Mogensen F; Scafidi A; Poli A; Michelucci A
J Neuroinflammation; 2023 Apr; 20(1):95. PubMed ID: 37072827
[TBL] [Abstract][Full Text] [Related]
28. Parkinson's disease-associated 18 bp promoter variant of DJ-1 alters REST binding and regulates its expression.
Pal P; Roy S; Chowdhury A; Chatterjee R; Ray K; Ray J
Neurosci Lett; 2023 Jan; 795():137051. PubMed ID: 36603736
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial LonP1 protease is implicated in the degradation of unstable Parkinson's disease-associated DJ-1/PARK 7 missense mutants.
Sánchez-Lanzas R; Castaño JG
Sci Rep; 2021 Apr; 11(1):7320. PubMed ID: 33795807
[TBL] [Abstract][Full Text] [Related]
30. Unexpected mitochondrial matrix localization of Parkinson's disease-related DJ-1 mutants but not wild-type DJ-1.
Kojima W; Kujuro Y; Okatsu K; Bruno Q; Koyano F; Kimura M; Yamano K; Tanaka K; Matsuda N
Genes Cells; 2016 Jul; 21(7):772-88. PubMed ID: 27270837
[TBL] [Abstract][Full Text] [Related]
31. DJ-1/PARK7: A New Therapeutic Target for Neurodegenerative Disorders.
Hijioka M; Inden M; Yanagisawa D; Kitamura Y
Biol Pharm Bull; 2017; 40(5):548-552. PubMed ID: 28458339
[TBL] [Abstract][Full Text] [Related]
32. Generation of integration-free human iPSC line LCPHi001-A from a Parkinson's disease patient carrying the RecNciI mutation in GBA gene.
Lu X; Song N; Wang W; Liu Y; Song H; Xu L; Wang Y; Wei C; Chen J; Yang X; Han F
Stem Cell Res; 2021 Oct; 56():102514. PubMed ID: 34464855
[TBL] [Abstract][Full Text] [Related]
33. PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains T
Danileviciute E; Zeng N; Capelle CM; Paczia N; Gillespie MA; Kurniawan H; Benzarti M; Merz MP; Coowar D; Fritah S; Vogt Weisenhorn DM; Gomez Giro G; Grusdat M; Baron A; Guerin C; Franchina DG; Léonard C; Domingues O; Delhalle S; Wurst W; Turner JD; Schwamborn JC; Meiser J; Krüger R; Ranish J; Brenner D; Linster CL; Balling R; Ollert M; Hefeng FQ
Nat Metab; 2022 May; 4(5):589-607. PubMed ID: 35618940
[TBL] [Abstract][Full Text] [Related]
34. Private variants in PRKN are associated with late-onset Parkinson's disease.
Hopfner F; Mueller SH; Szymczak S; Junge O; Tittmann L; May S; Lohmann K; Grallert H; Lieb W; Strauch K; Müller-Nurasyid M; Berger K; Schormair B; Winkelmann J; Mollenhauer B; Trenkwalder C; Maetzler W; Berg D; Kasten M; Klein C; Höglinger GU; Gasser T; Deuschl G; Franke A; Krawczak M; Dempfle A; Kuhlenbäumer G
Parkinsonism Relat Disord; 2020 Jun; 75():24-26. PubMed ID: 32442813
[No Abstract] [Full Text] [Related]
35. The apparent deglycase activity of DJ-1 results from the conversion of free methylglyoxal present in fast equilibrium with hemithioacetals and hemiaminals.
Andreeva A; Bekkhozhin Z; Omertassova N; Baizhumanov T; Yeltay G; Akhmetali M; Toibazar D; Utepbergenov D
J Biol Chem; 2019 Dec; 294(49):18863-18872. PubMed ID: 31653696
[TBL] [Abstract][Full Text] [Related]
36. Novel Redox-Dependent Esterase Activity (EC 3.1.1.2) for DJ-1: Implications for Parkinson's Disease.
Vázquez-Mayorga E; Díaz-Sánchez ÁG; Dagda RK; Domínguez-Solís CA; Dagda RY; Coronado-Ramírez CK; Martínez-Martínez A
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556455
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Motor and Non-Motor Behavioral Alterations in the Dj-1 (PARK7) Knockout Rat.
Kyser TL; Dourson AJ; McGuire JL; Hemmerle AM; Williams MT; Seroogy KB
J Mol Neurosci; 2019 Oct; 69(2):298-311. PubMed ID: 31250274
[TBL] [Abstract][Full Text] [Related]
38. Parkinson's disease-related DJ-1 functions in thiol quality control against aldehyde attack in vitro.
Matsuda N; Kimura M; Queliconi BB; Kojima W; Mishima M; Takagi K; Koyano F; Yamano K; Mizushima T; Ito Y; Tanaka K
Sci Rep; 2017 Oct; 7(1):12816. PubMed ID: 28993701
[TBL] [Abstract][Full Text] [Related]
39. Loss of park7 activity has differential effects on expression of iron responsive element (IRE) gene sets in the brain transcriptome in a zebrafish model of Parkinson's disease.
Chin HY; Lardelli M; Collins-Praino L; Barthelson K
Mol Brain; 2021 May; 14(1):83. PubMed ID: 34030724
[TBL] [Abstract][Full Text] [Related]
40. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.
Bandopadhyay R; Kingsbury AE; Cookson MR; Reid AR; Evans IM; Hope AD; Pittman AM; Lashley T; Canet-Aviles R; Miller DW; McLendon C; Strand C; Leonard AJ; Abou-Sleiman PM; Healy DG; Ariga H; Wood NW; de Silva R; Revesz T; Hardy JA; Lees AJ
Brain; 2004 Feb; 127(Pt 2):420-30. PubMed ID: 14662519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
